Chronic myelogenous leukemia (CML)CML; Chronic myeloid leukemia; CGL; Chronic granulocytic leukemia; Leukemia - chronic granulocytic
Chronic myelogenous leukemia (CML) is cancer that starts inside bone marrow. This is the soft tissue in the center of bones that helps form all blood cells.
CML causes an uncontrolled growth of immature and mature cells that make a certain type of white blood cell called myeloid cells. The diseased cells build up in the bone marrow and blood.
Kantarjian H, Cortes J. Chronic myeloid leukemia. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff's Clinical Oncology. 5th ed. Philadelphia, PA: Elsevier Saunders; 2014:chap 101.
National Cancer Institute website. Chronic myelogenous leukemia treatment (PDQ) – health professional version. www.cancer.gov/types/leukemia/hp/cml-treatment-pdq. Updated February 7, 2018. Accessed March 22, 2018.
National Comprehensive Cancer Network website. NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia (NCCN guidelines). Version 4.2018. www.nccn.org/professionals/physician_gls/pdf/cml.pdf. Updated January 24, 2018. Accessed March 22, 2018.